Literature DB >> 10725420

Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1.

M Saifuddin1, M L Hart, H Gewurz, Y Zhang, G T Spear.   

Abstract

Mannose-binding lectin (MBL) is present in human serum and plays an important role in innate immunity by binding to carbohydrate on micro-organisms. Whereas the gp120/gp41 of human immunodeficiency virus type 1 (HIV-1) contains numerous N-linked glycosylation sites and many of these sites contain high-mannose glycans which could interact with MBL, the interaction between MBL and primary isolates (PI) of HIV-1 has not been studied. To determine if PI of HIV bind to MBL, a virus capture assay was developed in which virus was incubated in MBL-coated microtitre wells followed by detection of bound virus with an ELISA for p24 antigen. The X4 HIV-1(MN) T cell line-adapted strain and PI of HIV (R5 and X4) bound to MBL. Binding of virus to MBL was via the carbohydrate-recognition domain of MBL since binding did not occur in the absence of Ca(2+) and was blocked by preincubation of MBL-coated wells with soluble mannan. The interaction of virus with MBL-coated wells was also inhibited by preincubation of virus with soluble MBL, indicating that both immobilized and soluble forms of MBL bound to HIV. Although host cell glycoproteins are incorporated into the membrane of HIV, binding of virus to immobilized MBL required expression of gp120/gp41 on virus particles, suggesting the presence of either an unusually high carbohydrate density and/or a unique carbohydrate structure on gp120/gp41 that is the target of MBL. This study shows that PI of HIV bind to MBL and suggests that MBL can selectively interact with HIV in vivo via carbohydrate structures on gp120/gp41.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725420     DOI: 10.1099/0022-1317-81-4-949

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  40 in total

1.  Genetic testing and HIV dementia: teasing out the molecular mechanisms of disease.

Authors:  Jay Rappaport; Joseph R Berger
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

2.  Characterization of glycopeptides from HIV-I(SF2) gp120 by liquid chromatography mass spectrometry.

Authors:  Jenny M Cutalo; Leesa J Deterding; Kenneth B Tomer
Journal:  J Am Soc Mass Spectrom       Date:  2004-11       Impact factor: 3.109

Review 3.  The good and evil of complement activation in HIV-1 infection.

Authors:  Qigui Yu; Richard Yu; Xuebin Qin
Journal:  Cell Mol Immunol       Date:  2010-03-15       Impact factor: 11.530

Review 4.  Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis.

Authors:  Florent Colomb; Leila B Giron; Irena Trbojevic-Akmacic; Gordan Lauc; Mohamed Abdel-Mohsen
Journal:  Curr HIV/AIDS Rep       Date:  2019-04       Impact factor: 5.071

Review 5.  Complement and HIV-I infection/HIV-associated neurocognitive disorders.

Authors:  Fengming Liu; Shen Dai; Jennifer Gordon; Xuebin Qin
Journal:  J Neurovirol       Date:  2014-03-18       Impact factor: 2.643

6.  How does mother-to-child transmission of HIV differ among African populations? Lessons from MBL2 genetic variation in Zimbabweans.

Authors:  Kudakwashe Mhandire; Gavin Pharo; Gwendolene Q Kandawasvika; Kerina Duri; Marelize Swart; Babill Stray-Pedersen; Collet Dandara
Journal:  OMICS       Date:  2014-03-06

Review 7.  Complementopathies and precision medicine.

Authors:  Eleni Gavriilaki; Robert A Brodsky
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

8.  Expression of mannose binding lectin in HIV-1-infected brain: implications for HIV-related neuronal damage and neuroAIDS.

Authors:  Kumud K Singh; Satyanarayana Nathamu; Anthony Adame; Tara U Alire; Wilmar Dumaop; Ben Gouaux; David J Moore; Eliezer Masliah
Journal:  Neurobehav HIV Med       Date:  2011-05-01

9.  Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection.

Authors:  Jan Balzarini; Sigrid Hatse; Kurt Vermeire; Katrien Princen; Stefano Aquaro; Carlo-Federico Perno; Erik De Clercq; Herman Egberink; Guy Vanden Mooter; Willy Peumans; Els Van Damme; Dominique Schols
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

10.  Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin.

Authors:  Gregory T Spear; M Reza Zariffard; Ji Xin; Mohammed Saifuddin
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.